Details

NameSymbolSector
OXYGENTA PHARMACEUTICAL LIMITEDOXYGENTAPHPharmaceuticals
Open
67.99
High
69.06
Low
67.71
Close
68.97
Volume
2618
Exchange
bse
Time
03-Oct-2025

Outlook

Score:  

3

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Oxygenta Pharmaceutical is  
Closing Marubozu
Estimated Stoploss of Oxygenta Pharmaceutical is ₹  
67.71
Oxygenta Pharmaceutical has a  
Bullishℹ
 pattern. 
Formation of  
Closing Marubozu
 candle pattern indicates Oxygenta Pharmaceutical has chances of  
Continuationℹ
 of the current trend. 

Trend

Oxygenta Pharmaceutical is in  
Sideways trendℹ
. 
Price of Oxygenta Pharmaceutical is  
Downℹ
 by  

12.57

%. 
Target
Buy @ 

54.57

Sell @ 

121.61

Current @ 

68.97

Volume

The trade volumes of Oxygenta Pharmaceutical have become  
Deficientℹ
The volume trend for Oxygenta Pharmaceutical is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Oxygenta Pharmaceutical is  

Down

 by  

56.22

% 

Valuation

The current market price of Oxygenta Pharmaceutical is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 82cr and total assets worth ₹ 82cr, the balance sheet of Oxygenta Pharmaceutical is:  
Balancedℹ
. 
Cashflow
Oxygenta Pharmaceutical has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2025)

9.52% i.e. ₹ 2cr earned in operatingℹ
52.38% i.e. ₹ 11cr spent in investingℹ
38.1% i.e. ₹ 8cr earned in financingℹ
0% in otherℹ
Oxygenta Pharmaceutical has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

38.24% i.e. ₹ 13cr spent in operatingℹ
11.76% i.e. ₹ 4cr spent in investingℹ
50% i.e. ₹ 17cr earned in financingℹ
0% in otherℹ
Income
The income of Oxygenta Pharmaceutical is  

₹ 15cr

 and  

Loss

 is :  

₹ 6cr

(*Jun 2025)

Oxygenta Pharmaceutical Losses increased by:  

200

% and Income is Down by:  

69.39

% 

(*Jun 2025)

The income of Oxygenta Pharmaceutical is  

₹ 49cr

 and  

Loss

 is :  

₹ 2cr

(*Mar 2025)

Oxygenta Pharmaceutical Losses decreased by:  

33.33

% and Income is Up by:  

48.48

% 

(*Mar 2025)

The income of Oxygenta Pharmaceutical is  

₹ 33cr

 and  

Loss

 is :  

₹ 3cr

(*Dec 2024)

Oxygenta Pharmaceutical Losses increased by:  

50

% and Income is Up by:  

135.71

% 

(*Dec 2024)

By using this site you agree to the use of cookies to deliver a better site experience.